SOUTHBOROUGH, Mass. – (February 16, 2022) – Virtusa today announced that it has been identified as a Sample Vendor in two areas of the Gartner Hype Cycle for Life Science Research and Development, 2021. With the report focusing on healthcare and life science digital transformation and innovation, Virtusa was mentioned in the Trial Simulation and RWD-Based Trials categories. 
Trial simulation is critical in life sciences because as digital technology matures and becomes pervasive within clinical development organizations, clinical and IT leaders must move from operational analytics to predictive analytics and simulation approaches to better plan, optimize and execute clinical trials. Virtusa‘s synthetic data generator is used to generate cohorts and train predictive models for disease progression or risk stratification.
Real World Data (RWD) trials play a key role in optimizing trial activities, with applications that deliver improvements to patient recruitment and retention, protocol optimization, trial feasibility, and safety signal detection. As RWD becomes more readily available, life science companies and vendors are leveraging it to drive insights on patient safety, examine comorbidities and study drug interactions.
Virtusa enables clients to use various RWD sources - electronic health records, point of sale pharmacy data and payer claims data – which have proven to be extremely useful to clinical development in RWD analytics solutions.
As life science companies continue to build out digital capabilities, the constantly shifting technology landscape requires diligent recalibration. This Hype Cycle explores innovative technologies relevant to life science R&D product development programs in the pharmaceutical, biotechnology, medical device, diagnostics, research institution and contract research sectors.
“One of Virtusa’s main focuses is helping life science companies build out their digital capabilities and facilitate strategic, tactical, and operational decision-making for clients by building an ecosystem to transform raw data into actionable insights with data governance, visualization, data exploratory analysis, and data platform modernization,” said Anthony Lange, Senior Vice President, healthcare, and life sciences at Virtusa. We have built vLife™, our own healthcare and life sciences marketplace and diverse set of solutions to address various challenges unique to the industry. “Being mentioned by Gartner as a sample vendor in two categories further reinforces our solutions’ values to our customers.”
 Gartner, “Hype Cycle for Life Science Research and Development, 2021” By Analyst(s): Jeff Smith, Michael Shanler; July 19, 2021.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER and HYPE CYCLE are trademarks and service marks of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.